All-cause mortality after five years is much more likely if a TAVR patient presents with CAD, according to a new analysis published in JACC: Cardiovascular Interventions.

A 31-year-old patient developed acute myocarditis shortly after the onset of monkeypox symptoms. The team that treated him shared their story in a new case study.

“Religiosity and spirituality may serve as buffers to stress and have therapeutic effects," according to one Mayo Clinic cardiologist involved in the study. 

Though removal of the affected CIED is typically the smartest treatment option—and one supported by specialty groups all over the world—a majority of patients keep living with the device, often resulting in hospitalization or even death.

After finding success in Europe, the company is focused on gaining FDA approval for its Trilogy Heart Valve System and launching the device in the United States. 

Researchers used data from more than 420,000 patients to develop a new AI-powered risk score that could help women receive much better care. 

Philippe Genereux, MD, medical director of the structural heart disease program at Morristown Medical Center, discusses the various options used for temporary pacing of the heart during transcatheter aortic valve replacement (TAVR) procedures.

A new article published by the Radiological Society of North America shares valuable commentary from experts in the field regarding how the medical industry can prepare for supply shortages in the future.